| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $251.7M | $418.8M | $527.1M |
| YoY Revenue Growth % | -39.9% | -20.5% | — |
| Gross Profit | $183.8M | $287.3M | — |
| Gross Margin % | 73.0% | 68.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.5M | -$66.2M | -$141.0M |
| Operating Margin % | 2.2% | -15.8% | -26.7% |
| Net Income (GAAP) | -$2.9M | -$71.6M | -$152.6M |
| EBITDA (Normalized) | $9.0M | -$62.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $21.8M | $2.6M | -$22.5M |
| Capital Expenditures (CapEx) | $4.4M | $4.5M | — |
| Free Cash Flow (FCF) | $17.4M | -$2.0M | -$22.5M |
| FCF Margin % | 6.9% | -0.5% | -4.3% |
| Return on Invested Capital (ROIC %) | 29.4% | -45.0% | — |
| Cash & Short-Term Equivalents | $39.0M | $20.2M | — |
| Total Debt (Short + Long Term) | $22.6M | $9.7M | — |
| Total Stockholders' Equity | $31.3M | $28.2M | — |